OSLO UNIVERSITETSSYKEHUS HF
- Country
- Norway
- Type
- Beneficiary
- Website
- www.oslo-universitetssykehus.no
- Grants received
- 127
Funding record
- 127 grants on record
- €64,437,452.61 awarded in total
- 2008–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
- Horizon Europe Framework Programme
- Seventh Framework Programme
- Horizon 2020 Framework Programme
- European Research Council
48 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- Universitetet i Oslo
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- KAROLINSKA INSTITUTET
- REGION HOVEDSTADEN
- Katholieke Universiteit Leuven
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
Calls from this organisation
No published calls from this organisation.
Grants received
- Competence Center for Theranostics and Radiopharmaceutical Excellence in the Baltic Region
- Innovative Radiation Therapy for brain tumors
- PERSONALISED NUTRITIONAL CARE FOR OLDER PATIENTS WITH LEUKAEMIA OR PANCREATIC CANCER – A PRAGMATIC IMPLEMENTATION TRIAL TO IMPROVE QUALITY OF LIFE
- CDT-net: The Cardiovascular Digital Twin Network
- ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond
- Prioritising multimodal surgical care for patients with locally advanced pancreatic cancer across Europe
- INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II
- National CAncer data Node DeveLopErs
- Accurate quantification of neurologic disease over time
- Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
- EUropean Cancer Information Portal
- Fatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axis
- Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer
- Specific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination
- Training network for tracking and controlling therapeutic immune cells in cancer
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.